Nutrition and Clinical Services Division, icddr,b, Dhaka1212, Bangladesh.
Faculty of Medicine and Life Sciences, University of Tampere, Tampere33520, Finland.
Public Health Nutr. 2021 Aug;24(11):3361-3370. doi: 10.1017/S1368980020001421. Epub 2020 Jul 3.
Chronic aflatoxin exposure has been associated with childhood stunting (length-for-age/height-for-age < -2 sd), while data lacks for Bangladesh, a country with substantial burden of childhood stunting. This paper examined the association between aflatoxin exposure and childhood stunting in a slum setting of Dhaka city.
In this MAL-ED aflatoxin birth cohort study, plasma samples were assayed for aflatoxin B1-lysine adduct (AFB1-lys) by MS at 7, 15, 24 and 36 months of age for 208, 196, 173 and 167 children to assess chronic aflatoxin exposure. Relationship between aflatoxin exposure and anthropometric measures was examined by mixed-effects logistic regression models.
The study was conducted in Mirpur, Dhaka, where children were followed from birth to 36 months.
Prevalence of stunting increased from 21 % at 7 months to 49 % at 36 months of age. Mean AFB1-lys concentrations at 7, 15, 24 and 36 months were 1·30 (range 0·09-5·79), 1·52 (range 0·06-6·35), 3·43 (range 0·15-65·60) and 3·70 (range 0·09-126·54) pg/mg albumin, respectively, and the percentage of children with detectable AFB1-lys was 10, 21, 18 and 62 %, respectively. No association was observed between aflatoxin exposure and stunting in multivariable analyses. Factors associated with childhood stunting were age, low birth weight, maternal height, stool myeloperoxidase and number of people sleeping in one room.
A relatively lower exposure to aflatoxin may not influence the linear growth of children. This finding indicates a threshold level of exposure for linear growth deficit and further investigation in other areas where higher concentrations of aflatoxin exposure exist.
慢性黄曲霉毒素暴露与儿童发育迟缓(年龄别身长/身高别身长<-2 个标准差)有关,而孟加拉国是儿童发育迟缓负担沉重的国家,却缺乏相关数据。本文研究了达卡市贫民窟环境中黄曲霉毒素暴露与儿童发育迟缓之间的关系。
在这项 MAL-ED 黄曲霉毒素出生队列研究中,在 7、15、24 和 36 个月时,通过 MS 测定 208、196、173 和 167 名儿童的血浆样本中的黄曲霉毒素 B1-赖氨酸加合物(AFB1-lys),以评估慢性黄曲霉毒素暴露情况。采用混合效应逻辑回归模型研究黄曲霉毒素暴露与人体测量指标之间的关系。
研究在达卡的米尔普尔进行,从出生到 36 个月对儿童进行随访。
7 个月时发育迟缓的患病率为 21%,36 个月时增至 49%。7、15、24 和 36 个月时的平均 AFB1-lys 浓度分别为 1.30(范围 0.09-5.79)、1.52(范围 0.06-6.35)、3.43(范围 0.15-65.60)和 3.70(范围 0.09-126.54)pg/mg 白蛋白,分别有 10%、21%、18%和 62%的儿童可检测到 AFB1-lys。多变量分析显示,黄曲霉毒素暴露与发育迟缓之间无关联。与儿童发育迟缓相关的因素有年龄、低出生体重、母亲身高、粪便髓过氧化物酶和一个房间内睡觉的人数。
相对较低水平的黄曲霉毒素暴露可能不会影响儿童的线性生长。这一发现表明存在一个线性生长缺陷的暴露阈值水平,需要在黄曲霉毒素暴露浓度更高的其他地区进一步研究。